193 related articles for article (PubMed ID: 10855193)
1. How growth factors help chronic wounds heal.
Barry M
Nursing; 2000 May; 30(5):52-3. PubMed ID: 10855193
[No Abstract] [Full Text] [Related]
2. Growth factors and chronic wound healing: past, present, and future.
Goldman R
Adv Skin Wound Care; 2004; 17(1):24-35. PubMed ID: 14752324
[TBL] [Abstract][Full Text] [Related]
3. The future of recombinant growth factors in wound healing.
Robson MC; Mustoe TA; Hunt TK
Am J Surg; 1998 Aug; 176(2A Suppl):80S-82S. PubMed ID: 9777977
[TBL] [Abstract][Full Text] [Related]
4. Specific growth factors and the healing of chronic wounds.
Krishnamoorthy L; Morris HL; Harding KG
J Wound Care; 2001 May; 10(5):173-8. PubMed ID: 12964325
[No Abstract] [Full Text] [Related]
5. 3 cases of aberrant wound healing in acute myelogenous leukemia.
Smith L; Gallison B; Siegler EL
Adv Skin Wound Care; 2005; 18(9):473-6. PubMed ID: 16365543
[No Abstract] [Full Text] [Related]
6. Using angiogenesis in chronic wound care with becaplermin and oxidized regenerated cellulose/collagen.
Hollister C; Li VW
Nurs Clin North Am; 2007 Sep; 42(3):457-65, vii. PubMed ID: 17825664
[TBL] [Abstract][Full Text] [Related]
7. The use of growth factors in clinical practice.
Graham A
J Wound Care; 1998 Nov; 7(10):536-40. PubMed ID: 10188449
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcers.
Sibbald RG; Torrance G; Hux M; Attard C; Milkovich N
Ostomy Wound Manage; 2003 Nov; 49(11):76-84. PubMed ID: 14652415
[TBL] [Abstract][Full Text] [Related]
9. The new (or at least newer) kids on the block: new technology in wound care.
Worley CA
Dermatol Nurs; 2005 Oct; 17(5):377, 380. PubMed ID: 16294946
[No Abstract] [Full Text] [Related]
10. Beyond sympathy. Growth factors may help heal stubborn wounds.
Erickson D
Sci Am; 1991 Dec; 265(6):141. PubMed ID: 1754871
[No Abstract] [Full Text] [Related]
11. Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers.
Nagai MK; Embil JM
Expert Opin Biol Ther; 2002 Feb; 2(2):211-8. PubMed ID: 11849120
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of platelet-derived growth factor BB in accelerating wound healing in aged versus young animals: the impact of tissue hypoxia.
Wu L; Brucker M; Gruskin E; Roth SI; Mustoe TA
Plast Reconstr Surg; 1997 Mar; 99(3):815-22; discussion 823-4. PubMed ID: 9047202
[TBL] [Abstract][Full Text] [Related]
13. Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects.
Larivière B; Rouleau M; Picard S; Beaulieu AD
Wound Repair Regen; 2003; 11(1):79-89. PubMed ID: 12581430
[TBL] [Abstract][Full Text] [Related]
14. Use of becaplermin gel and Kollagen Medifil particles.
Tomaselli NL
J Wound Ostomy Continence Nurs; 2000 Nov; 27(6):319-20. PubMed ID: 11096412
[No Abstract] [Full Text] [Related]
15. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers.
Miller MS
J Foot Ankle Surg; 1999; 38(3):227-31. PubMed ID: 10384364
[TBL] [Abstract][Full Text] [Related]
16. Growth factors: the wound healing therapy of the future.
Carter K
Br J Community Nurs; 2003 Sep; 8(9):S15-6, S18-9, S22-3. PubMed ID: 14535245
[TBL] [Abstract][Full Text] [Related]
17. Treatment of scleroderma skin ulcers using becaplermin gel and hydrocolloid membrane.
Yoon J; Giacopelli J; Granoff D; Kobayashi W
J Am Podiatr Med Assoc; 2002 Jun; 92(6):350-4. PubMed ID: 12070235
[TBL] [Abstract][Full Text] [Related]
18. Optimizing healing of the acute wound by minimizing complications.
Franz MG; Steed DL; Robson MC
Curr Probl Surg; 2007 Nov; 44(11):691-763. PubMed ID: 18036992
[No Abstract] [Full Text] [Related]
19. Preclinical promise of becaplermin (rhPDGF-BB) in wound healing.
LeGrand EK
Am J Surg; 1998 Aug; 176(2A Suppl):48S-54S. PubMed ID: 9777972
[TBL] [Abstract][Full Text] [Related]
20. [Approval for recombinant growth factor. Since January 2000, patients with diabetic foot ulcers can be treated with the growth factor becaplermin (Regranex), manufactured with genetic technology].
Fruhstorfer B
Internist (Berl); 2000 Jan; 41(1):A38. PubMed ID: 10712088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
